trending Market Intelligence /marketintelligence/en/news-insights/trending/FD8JBoQw-atVD6EtQ4221Q2 content esgSubNav
In This List

Protagonist Therapeutics appoints director

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Protagonist Therapeutics appoints director

Protagonist Therapeutics, Inc. appointed Sarah Noonberg to the board, replacing Julie Grant.

Noonberg is the chief medical officer of Prothena Corp. plc. Grant, who has stepped down from the board, is a partner at Canaan Partners.